These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 7531116)
1. Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line. Montel AH; Morse PA; Brahmi Z Cell Immunol; 1995 Jan; 160(1):104-14. PubMed ID: 7531116 [TBL] [Abstract][Full Text] [Related]
2. Fas involvement in cytotoxicity mediated by human NK cells. Montel AH; Bochan MR; Hobbs JA; Lynch DH; Brahmi Z Cell Immunol; 1995 Dec; 166(2):236-46. PubMed ID: 7497525 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672 [TBL] [Abstract][Full Text] [Related]
5. Expression and function of CD28 on Epstein-Barr virus-positive B cell lines and AIDS-associated non-Hodgkin's lymphoma cell lines. Widney D; Boscardin WJ; Kasravi A; Martínez-Maza O Tumour Biol; 2003; 24(2):82-93. PubMed ID: 12853703 [TBL] [Abstract][Full Text] [Related]
6. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD; Rowe M; Rickinson AB J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis. Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728 [TBL] [Abstract][Full Text] [Related]
8. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649 [TBL] [Abstract][Full Text] [Related]
10. Detection of Epstein-Barr virus genome in natural-killer-like cell line, YT. Yoneda N; Tatsumi E; Kawano S; Teshigawara K; Oka T; Fukuda M; Yamaguchi N Leukemia; 1992 Feb; 6(2):136-41. PubMed ID: 1313126 [TBL] [Abstract][Full Text] [Related]
11. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of CD28-mediated natural cytotoxicity by KIR2DL2 does not require p56(lck) in the NK cell line YT-Indy. Tarazona R; Borrego F; Galiani MD; Aguado E; Peña J; Coligan JE; Solana R Mol Immunol; 2002 Jan; 38(7):495-503. PubMed ID: 11750651 [TBL] [Abstract][Full Text] [Related]
13. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL J Immunol; 1992 Aug; 149(4):1115-23. PubMed ID: 1380031 [TBL] [Abstract][Full Text] [Related]
14. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208 [TBL] [Abstract][Full Text] [Related]
15. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines. Kis LL; Takahara M; Nagy N; Klein G; Klein E Blood; 2006 Apr; 107(7):2928-35. PubMed ID: 16332968 [TBL] [Abstract][Full Text] [Related]
16. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Nakagomi H; Dolcetti R; Bejarano MT; Pisa P; Kiessling R; Masucci MG Int J Cancer; 1994 Apr; 57(2):240-4. PubMed ID: 8157362 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. Allday MJ; Crawford DH; Thomas JA J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171 [TBL] [Abstract][Full Text] [Related]
18. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466 [TBL] [Abstract][Full Text] [Related]
19. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1. Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693 [TBL] [Abstract][Full Text] [Related]
20. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]